Katie O’Callaghan

1.1k total citations
19 papers, 904 citations indexed

About

Katie O’Callaghan is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Katie O’Callaghan has authored 19 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Katie O’Callaghan's work include Blood Coagulation and Thrombosis Mechanisms (5 papers), CAR-T cell therapy research (4 papers) and Multiple Myeloma Research and Treatments (4 papers). Katie O’Callaghan is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (5 papers), CAR-T cell therapy research (4 papers) and Multiple Myeloma Research and Treatments (4 papers). Katie O’Callaghan collaborates with scholars based in United States, Ireland and Italy. Katie O’Callaghan's co-authors include Lidija Covic, Athan Kuliopulos, Adrienne Boire, Nicole C. Kaneider, Eric Yang, Anika Agarwal, Nga Nguyen, Boris Tchernychev, Andrew J. Leger and Vishal Trivedi and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Circulation.

In The Last Decade

Katie O’Callaghan

19 papers receiving 892 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katie O’Callaghan United States 11 480 301 223 153 143 19 904
Angela Russo United States 20 537 1.1× 151 0.5× 141 0.6× 142 0.9× 45 0.3× 38 1.0k
Y. Eric Shi United States 15 406 0.8× 157 0.5× 413 1.9× 330 2.2× 114 0.8× 22 897
Mousumi Majumdar United States 9 585 1.2× 157 0.5× 208 0.9× 74 0.5× 66 0.5× 9 872
Andrew J. Leger United States 14 827 1.7× 546 1.8× 308 1.4× 116 0.8× 323 2.3× 16 1.6k
Raudel Sandoval United States 13 504 1.1× 197 0.7× 116 0.5× 137 0.9× 73 0.5× 15 1.0k
Daryoush Ekhterae United States 17 792 1.6× 177 0.6× 134 0.6× 222 1.5× 66 0.5× 21 1.2k
Fabienne Maurer Switzerland 15 598 1.2× 90 0.3× 147 0.7× 151 1.0× 91 0.6× 24 916
James Tunstead United States 19 611 1.3× 329 1.1× 71 0.3× 503 3.3× 52 0.4× 22 1.3k
Baby G. Tholanikunnel United States 22 585 1.2× 135 0.4× 83 0.4× 94 0.6× 59 0.4× 33 1.0k
Charlotte E. Edling United Kingdom 14 606 1.3× 74 0.2× 124 0.6× 273 1.8× 33 0.2× 32 1.0k

Countries citing papers authored by Katie O’Callaghan

Since Specialization
Citations

This map shows the geographic impact of Katie O’Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie O’Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie O’Callaghan more than expected).

Fields of papers citing papers by Katie O’Callaghan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie O’Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie O’Callaghan. The network helps show where Katie O’Callaghan may publish in the future.

Co-authorship network of co-authors of Katie O’Callaghan

This figure shows the co-authorship network connecting the top 25 collaborators of Katie O’Callaghan. A scholar is included among the top collaborators of Katie O’Callaghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie O’Callaghan. Katie O’Callaghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhang, Keming, et al.. (2025). Abstract LB360: Discovery and development of fully human IL13Ra2/B7H3 bispecific armored CAR-T for treatment of glioblastoma. Cancer Research. 85(8_Supplement_2). LB360–LB360. 1 indexed citations
2.
O’Callaghan, Katie, et al.. (2023). Abstract LB188: Discovery and development of fully human TACI/BCMA bispecific armored CAR for the treatment of relapsed/refractory multiple myeloma. Cancer Research. 83(8_Supplement). LB188–LB188. 1 indexed citations
3.
Amidon, Benjamin, Jill Cavanaugh, Katie O’Callaghan, et al.. (2021). Abstract P216: IK-930 mediated TEAD inhibition decreases and delays tumor growth and enhances targeted apoptosis in lung and colon cancer xenografts when combined with MEK or EGFR inhibitors. Molecular Cancer Therapeutics. 20(12_Supplement). P216–P216. 7 indexed citations
4.
McGovern, Karen, Alfredo Castro, Jill Cavanaugh, et al.. (2020). 448 Discovery of clinical candidate IK-175, a selective orally active AHR antagonist. Regular and Young Investigator Award Abstracts. A272.1–A272. 3 indexed citations
5.
O’Callaghan, Katie, Allison Nelson, Greg Motz, et al.. (2017). Adaptability of Antibody-Coupled T Cell Receptor (ACTR) Engineered Autologous T Cells in Combination with Daratumumab over CAR-Based Approaches. Blood. 130. 3189–3189. 2 indexed citations
6.
Cheema, Tooba A., Katie O’Callaghan, Lori Westendorf, et al.. (2017). Abstract 4605: Efficient targeting of BCMA-positive multiple myeloma cells by antibody-coupled T-cell receptor (ACTR) engineered autologous T cells in combination with an anti-BCMA antibody. Cancer Research. 77(13_Supplement). 4605–4605. 1 indexed citations
7.
Yang, Eric, Jarosław Cisowski, Nga Nguyen, et al.. (2015). Dysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2. Oncogene. 35(12). 1529–1540. 43 indexed citations
8.
Deckert, Jutta, Callum M. Sloss, Katie O’Callaghan, et al.. (2015). IMGN529, a Novel Antibody-Drug Conjugate (ADC) Targeting CD37 Shows Synergistic Activity with Rituximab in Non-Hodgkin Lymphoma (NHL) Models. Blood. 126(23). 1548–1548. 3 indexed citations
9.
O’Connell, Brenda, Katie O’Callaghan, Bonnie Tillotson, et al.. (2014). HSP90 Inhibition Enhances Antimitotic Drug-Induced Mitotic Arrest and Cell Death in Preclinical Models of Non-Small Cell Lung Cancer. PLoS ONE. 9(12). e115228–e115228. 14 indexed citations
10.
O’Callaghan, Katie, Athan Kuliopulos, & Lidija Covic. (2012). Turning Receptors On and Off with Intracellular Pepducins: New Insights into G-protein-coupled Receptor Drug Development. Journal of Biological Chemistry. 287(16). 12787–12796. 125 indexed citations
11.
Zhang, Ping, András Gruber, Shogo Kasuda, et al.. (2012). Suppression of Arterial Thrombosis Without Affecting Hemostatic Parameters With a Cell-Penetrating PAR1 Pepducin. Circulation. 126(1). 83–91. 62 indexed citations
12.
Foley, Caitlin, Chi Luo, Katie O’Callaghan, et al.. (2012). Matrix Metalloprotease-1a Promotes Tumorigenesis and Metastasis. Journal of Biological Chemistry. 287(29). 24330–24338. 46 indexed citations
13.
Cisowski, Jarosław, Katie O’Callaghan, Athan Kuliopulos, et al.. (2011). Targeting Protease-Activated Receptor-1 with Cell-Penetrating Pepducins in Lung Cancer. American Journal Of Pathology. 179(1). 513–523. 75 indexed citations
14.
O’Callaghan, Katie, Lydia Lee, Nga Nguyen, et al.. (2011). Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia. Blood. 119(7). 1717–1725. 52 indexed citations
15.
Yang, Eric, Adrienne Boire, Anika Agarwal, et al.. (2009). Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis. Cancer Research. 69(15). 6223–6231. 121 indexed citations
16.
Trivedi, Vishal, Adrienne Boire, Boris Tchernychev, et al.. (2009). Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site. Cell. 137(2). 332–343. 190 indexed citations
17.
O’Callaghan, Katie, Verónica Ayllón, Yanru Wang, et al.. (2009). Heme-binding Protein HRG-1 Is Induced by Insulin-like Growth Factor I and Associates with the Vacuolar H+-ATPase to Control Endosomal pH and Receptor Trafficking. Journal of Biological Chemistry. 285(1). 381–391. 55 indexed citations
18.
O’Callaghan, Katie, et al.. (2009). CXCR4 Pepducins in Stem Cell Mobilization.. Blood. 114(22). 2440–2440. 2 indexed citations
19.
Floyd, Suzanne, Cédric Favre, Francesco M. Lasorsa, et al.. (2007). The Insulin-like Growth Factor-I–mTOR Signaling Pathway Induces the Mitochondrial Pyrimidine Nucleotide Carrier to Promote Cell Growth. Molecular Biology of the Cell. 18(9). 3545–3555. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angela Russo Breakdown of academic impact, for papers by Y. Eric Shi Breakdown of academic impact, for papers by Mousumi Majumdar Breakdown of academic impact, for papers by Andrew J. Leger Breakdown of academic impact, for papers by Raudel Sandoval Breakdown of academic impact, for papers by Daryoush Ekhterae Breakdown of academic impact, for papers by Fabienne Maurer Breakdown of academic impact, for papers by James Tunstead Breakdown of academic impact, for papers by Baby G. Tholanikunnel Breakdown of academic impact, for papers by Charlotte E. Edling
Rankless by CCL
2026